Company Filing History:
Years Active: 2008
Title: Larisa V Debelenko: Innovator in Tumor Suppressor Gene Discovery
Introduction: Larisa V Debelenko is an accomplished inventor based in New York, NY, who has made significant contributions to the field of medical genetics. With a focus on uncovering the genetic underpinnings of diseases, her work has the potential to revolutionize the diagnosis and treatment of endocrine disorders.
Latest Patents: Larisa V Debelenko holds a patent for a groundbreaking discovery related to a novel tumor suppressor gene associated with multiple endocrine neoplasia type 1. This gene, designated as MEN1, encodes a protein known as menin. The absence of this protein, along with mutations in the MEN1 gene, has been correlated with patients suffering from multiple endocrine neoplasia type 1. The identification of this genetic marker not only has diagnostic applications but also holds promise for advancements in gene therapy.
Career Highlights: Debelenko is currently employed by the Government of the United States of America as represented by the Secretary of the Department of Health and Human Services. Her career is distinguished by her strong commitment to advancing medical research and improving healthcare outcomes through innovative genetic discoveries.
Collaborations: Throughout her career, Larisa has collaborated with esteemed colleagues such as Settara Chandrasekharappa and Siradanahalli Guru. These professional partnerships have played a pivotal role in enhancing her research and expanding the impact of her innovations in genetics.
Conclusion: Larisa V Debelenko's contributions to medical research, particularly in the identification of the MEN1 gene, underline her importance as an inventor in the field of genetics. Her work not only paves the way for improved diagnostic methods but also opens doors for innovative therapeutic strategies, highlighting the critical role of inventors in advancing science and healthcare.